Clozapine in the treatment of psychosis in Parkinson's disease
Authors:
- 1 September 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (9) , 1219
Abstract
Clozapine is an antipsychotic medication that is virtually free of ertrapyramidal side effects. We report our successful treatment of 6 patients with idiopathic Parkinson9s disease and various psychoses using clozapine on a chronic basis along with carbidopa/L-dopa.Keywords
This publication has 14 references indexed in Scilit:
- TREATMENT OUTCOME WITH CLOZAPINE IN TARDIVE-DYSKINESIA, NEUROLEPTIC SENSITIVITY, AND TREATMENT-RESISTANT PSYCHOSIS1987
- Clozapine in the treatment of tremorActa Neurologica Scandinavica, 1986
- Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapineEuropean Archives of Psychiatry and Clinical Neuroscience, 1985
- NEUROLEPTIC AFFINITIES FOR HUMAN-BRAIN RECEPTORS AND THEIR USE IN PREDICTING ADVERSE-EFFECTS1984
- Reversible Drug-Induced ParkinsonismArchives of Neurology, 1982
- Clozapine: Plasma levels and prolactin responsePsychopharmacology, 1981
- SITE-SPECIFIC BLOCKADE OF DOPAMINE-RECEPTORS BY NEUROLEPTIC AGENTS IN HUMAN-BRAIN1981
- Effect of clozapine on human serum prolactin levelsAmerican Journal of Psychiatry, 1979
- The trial use of clozapine for abnormal involuntary movement disordersAmerican Journal of Psychiatry, 1979
- CLOZAPINE VERSUS CHLORPROMAZINE FOR THE TREATMENT OF SCHIZOPHRENIA - PRELIMINARY-RESULTS FROM A DOUBLE-BLIND-STUDY1979